| Literature DB >> 35627637 |
Nasturah Abdullah1, Noorhida Baharudin1, Mariam Mohamad2, Mohamed-Syarif Mohamed-Yassin1.
Abstract
Screening mammograms have resulted in a reduction in breast cancer mortality, yet the uptake in Malaysia was low. This study aimed to determine the prevalence and factors associated with screening mammogram uptake among women attending a Malaysian primary care clinic. A cross-sectional study was conducted among 200 women aged 40 to 74 attending the clinic. The data was collected using questionnaires assessing sociodemographic, clinical characteristics, knowledge and health beliefs. Multiple logistic regression was used to identify factors associated with mammogram uptake. The prevalence of screening mammograms was 46.0%. About 45.5% of women with high breast cancer risk had never undergone a mammogram. Older participants, aged 50 to 74 (OR = 2.57, 95% CI: 1.05, 6.29, p-value = 0.039) and those who received a physician's recommendation (OR = 7.61, 95% CI: 3.81, 15.20, p-value < 0.001) were more likely to undergo screening mammography. Significant health beliefs associated with mammogram uptake were perceived barriers (OR = 0.81, 95% CI: 0.67, 0.97, p-value = 0.019) and cues to action (OR = 1.30, 95% CI: 1.06, 1.59, p-value = 0.012). Approximately half of the participants and those in the high-risk group had never undergone a mammogram. Older age, physician recommendation, perceived barriers and cues to action were significantly associated with mammogram uptake. Physicians need to play an active role in promoting breast cancer screening and addressing the barriers.Entities:
Keywords: Malaysia; breast cancer screening; health belief; mammogram; primary care
Mesh:
Year: 2022 PMID: 35627637 PMCID: PMC9141597 DOI: 10.3390/ijerph19106103
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 4.614
Figure 1Flow chart of the study.
Sociodemographic and clinical characteristics of the participants, n = 200.
| Sociodemographic and Clinical Characteristics | Mean (SD) | Frequency, n (%) |
|---|---|---|
|
| 56.03 (7.75) | |
|
| ||
| 40–49 | 42 (21.0) | |
| 50–74 | 158 (79.0) | |
|
| ||
| Malay | 177 (88.5) | |
| Chinese | 11 (5.5) | |
| Indian | 12 (6.0) | |
|
| ||
| Single/divorced/widow | 31 (15.5) | |
| Married | 169 (84.5) | |
|
| ||
| Primary/secondary | 84 (42.0) | |
| Tertiary | 116 (58.0) | |
|
| ||
| Pensioner/unemployed | 116 (58.0) | |
| Employed | 84 (42.0) | |
|
| ||
| Bottom 40% (B40); <MYR4850 | 115 (57.5) | |
| Middle 40% (M40); MYR4850 to MYR10959 | 74 (37.0) | |
| Top 20% (T20); >MYR10959 | 11 (5.5) | |
|
| ||
| No | 130 (65.0) | |
| Yes | 70 (35.0) | |
|
| ||
| Hypertension | 112 (56.0) | |
| Dyslipidemia | 90 (45.0) | |
| Diabetes mellitus | 68 (34.0) | |
| Asthma | 20 (10.0) | |
|
| ||
| Have ever used oral contraceptive pills (OCP) | 50 (25.0) | |
| Family history of breast and/or ovarian cancer | 34 (17.0) | |
| Have ever used hormone replacement therapy (HRT) | 20 (10.0) | |
| Nulliparity | 18 (9.0) | |
| Alcohol consumption | 6 (3.0) | |
| Past chest irradiation treatment | 2 (1.0) | |
|
| ||
| Underweight/normal | 32 (16.0) | |
| Overweight/obese | 168 (84.0) | |
|
| ||
| >12 | 181 (90.5) | |
| ≤12 | 19 (9.5) | |
|
| ||
| <50 | 113 (80.7) | |
| ≥50 | 27 (19.3) | |
|
| ||
| Average-risk | 167 (83.5) | |
| High-risk | 33 (16.5) | |
|
| ||
| No | 76 (38.0) | |
| Yes | 124 (62.0) | |
|
| ||
| No | 34 (17.0) | |
| Yes | 166 (83.0) | |
|
| ||
| No | 120 (60.0) | |
| Yes | 80 (40.0) | |
|
| ||
| No | 62 (67.4) | |
| Yes | 30 (32.6) | |
|
| ||
| Personal interest | 58 (63.0) | |
| Physician recommendation | 26 (28.3) | |
| Others | 8 (8.7) | |
|
| ||
| No | 45 (41.7) | |
| Yes | 63 (58.3) |
^ Included only participants who had attained menopause, n = 140. * Included only participants who had undergone mammogram, n = 92. ** Included only participants who had never undergone mammogram, n = 108.
Prevalence of screening mammogram uptake according to age and breast cancer risk category.
| Variables | Yes | No | |
|---|---|---|---|
|
| 92 (46.0) | 108 (54.0) | - |
|
| |||
| <1 year | 8 (8.7) | - | - |
| 1 to 2 years | 14 (15.2) | - | - |
| >2 years | 70 (76.1) | - | - |
|
| |||
| 40 to 49 | 11 (26.2) | 31 (73.8) | 0.004 |
| 50 to 74 | 81 (51.3) | 77 (48.7) | |
|
| |||
| Average-risk | 74 (44.3) | 93 (55.7) | 0.281 |
| High-risk | 18 (54.5) | 15 (45.5) |
^ Included only participants who had undergone mammogram, n = 92.
The mean scores for knowledge and health beliefs.
| Variables | Mean (SD) | Minimum | Maximum |
|---|---|---|---|
|
| 16.37 (6.30) | 2.00 | 28.00 |
| Symptoms of breast cancer (0 to 7) | 4.09 (2.37) | 0.00 | 7.00 |
| Risk factors of breast cancer (0 to 7) | 2.16 (1.29) | 0.00 | 6.00 |
| Methods of breast screening (0 to 7) | 4.09 (1.96) | 0.00 | 7.00 |
| Perceptions on breast lump(s) (0 to 2) | 0.74 (0.84) | 0.00 | 2.00 |
| Knowledge on mammography (0 to 9) | 5.30 (2.19) | 0.00 | 9.00 |
|
| |||
| Perceived severity (1–10) | 6.61 (2.07) | 1.00 | 10.00 |
| Perceived susceptibility (1–10) | 4.34 (2.23) | 1.00 | 10.00 |
| Health motivation (1–10) | 7.78 (1.71) | 1.40 | 10.00 |
|
| |||
| Perceived benefit (1–10) | 7.94 (1.81) | 1.00 | 10.00 |
| Perceived barriers (1–10) | 4.51 (1.93) | 1.00 | 10.00 |
| Self-efficacy (1–10) | 7.37 (1.91) | 2.25 | 10.00 |
| Cues to action (1–10) | 8.07 (1.73) | 2.00 | 10.00 |
Association of sociodemographic, clinical factors, knowledge and health beliefs with screening mammogram uptake.
| Variables | Beta | Wald (df) | OR (95% CI) | |
|---|---|---|---|---|
|
| ||||
| 40–49 | 1 | |||
| 50–74 | 1.09 | 7.95 (1) | 2.97 (1.39, 6.31) |
|
|
| ||||
| Malay | 1 | |||
| Chinese | 0.38 | 0.36 (1) | 1.46 (0.43, 4.94) | 0.548 |
| Indian | 0.19 | 0.10 (1) | 1.21 (0.38, 3.91) | 0.747 |
|
| ||||
| Single/divorced/widow | 1 | |||
| Married | 0.20 | 0.24 (1) | 1.22 (0.56, 2.64) | 0.622 |
|
| ||||
| Primary/secondary | 1 | |||
| Tertiary | −0.03 | 0.01 (1) | 0.97 (0.55, 1.71) | 0.918 |
|
| ||||
| Pensioner/unemployed | 1 | |||
| Employed | −0.47 | 2.62 (1) | 0.63 (0.35, 1.11) | 0.106 |
|
| ||||
| Bottom 40% (B40); <MYR4850 | 1 | |||
| Middle 40% (M40); MYR4850 to MYR10959 | −0.15 | 0.25 (1) | 0.86 (0.48, 1.55) | 0.617 |
| Top 20% (T20); >MYR10959 | 0.30 | 0.23 (1) | 1.36 (0.39, 4.69) | 0.631 |
|
| ||||
| No | 1 | |||
| Yes | 0.25 | 0.69 (1) | 1.28 (0.72, 2.29) | 0.405 |
|
| ||||
| Diabetes mellitus | −0.25 | 0.01 (1) | 0.98 (0.54, 1.75) | 0.933 |
| Hypertension | −0.45 | 2.48 (1) | 0.64 (0.36, 1.12) | 0.115 |
| Dyslipidemia | 0.05 | 0.03 (1) | 1.05 (0.60, 1.84) | 0.864 |
| Asthma | 0.63 | 1.71 (1) | 1.88 (0.73, 4.81) | 0.191 |
|
| ||||
| Family history of breast and/or ovarian cancer | 0.34 | 0.79 (1) | 1.40 (0.67, 2.93) | 0.374 |
| Have ever used oral contraceptive pills (OCP) | 0.00 | 0.00 (1) | 1.00 (0.53, 1.90) | 1.000 |
| Have ever used hormone replacement therapy (HRT) | 0.87 | 3.09 (1) | 2.37 (0.91, 6.23) | 0.079 |
| Alcohol consumption | 0.17 | 0.04 (1) | 1.18 (0.23, 5.99) | 0.842 |
| Nulliparity | −0.07 | 0.02 (1) | 0.93 (0.35, 2.47) | 0.890 |
|
| ||||
| Underweight/normal | 1 | |||
| Overweight/obese | −0.49 | 1.59 (1) | 0.61 (0.29, 1.31) | 0.207 |
|
| ||||
| >12 | 1 | |||
| ≤12 | 0.06 | 0.02 (1) | 1.06 (0.41, 2.74) | 0.900 |
|
| ||||
| <50 | 1 | |||
| ≥50 | 0.02 | 0.00 (1) | 1.02 (0.44, 2.37) | 0.961 |
|
| ||||
| Average-risk | 1 | |||
| High-risk | 0.41 | 1.15 (1) | 1.51 (0.71, 3.19) | 0.283 |
|
| ||||
| No | 1 | |||
| Yes | 0.78 | 6.75 (1) | 2.19 (1.21, 3.95) |
|
|
| ||||
| No | 1 | |||
| Yes | 0.24 | 0.38 (1) | 1.27 (0.60, 2.68) | 0.536 |
|
| ||||
| No | 1 | |||
| Yes | 2.11 | 40.75 (1) | 8.25 (4.32, 15.77) |
|
|
| 0.05 | 4.67 (1) | 1.05 (1.01, 1.10) |
|
|
| ||||
| Perceived severity | 0.08 | 1.20 (1) | 1.08 (0.94, 1.24) | 0.274 |
| Perceived susceptibility | 0.06 | 0.80 (1) | 1.06 (0.93, 1.20) | 0.372 |
| Health motivation | 0.22 | 5.97 (1) | 1.24 (1.04, 1.48) |
|
|
| ||||
| Perceived benefit | 0.21 | 5.65 (1) | 1.23 (1.04, 1.46) |
|
| Perceived barriers | −0.21 | 7.41 (1) | 0.81 (0.70, 0.94) |
|
| Self-efficacy | 0.21 | 7.42 (1) | 1.24 (1.06, 1.45) |
|
| Cues to action | 0.27 | 8.70 (1) | 1.30 (1.09, 1.56) |
|
1 = Reference group. Emboldened: Statistical significance at p < 0.05. ^ Included only participants who had attained menopause, n = 140.
Factors associated with screening mammogram uptake.
| Variables | Adjusted Beta | Wald (df) | Adjusted OR (95% CI) | |
|---|---|---|---|---|
|
| ||||
| 40–49 | 1 | |||
| 50–74 | 0.94 | 4.26 (1) | 2.57 (1.05, 6.29) | 0.039 |
|
| ||||
| No | 1 | |||
| Yes | 2.03 | 33.02 (1) | 7.61 (3.81, 15.20) | <0.001 |
|
| ||||
| Perceived barriers | −0.22 | 5.54 (1) | 0.81 (0.67, 0.97) | 0.019 |
| Cues to action | 0.26 | 6.26 (1) | 1.30 (1.06, 1.59) | 0.012 |
The model fits well (X2 = 64.51, df = 4, n = 200, p < 0.05). Model assumptions were met, no significant interaction and multicollinearity.